Clinical Trials Directory

Trials / Completed

CompletedNCT02495051

Esophageal Atresia: Metaplasia, Barrett

Prevalence of Barrett's Esophagus in Adolescents and Young Adults With Esophageal Atresia

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
15 Years – 19 Years
Healthy volunteers
Not accepted

Summary

The frequency of Barrett's esophagus (BE) has increased in adults in the last decades, but BE is rare in children. Esophageal atresia (EA), the most common congenital anomaly affecting the esophagus, predisposes the patient to severe and prolonged gastroesophageal reflux disease. Because gastroesophageal reflux disease plays a major role in the development of BE by causing repeated mucosal damage, development of BE is a concern even in children and young adults in this specific population. The aim of this study is to assess the prevalence of BE (gastric and/or intestinal metaplasia) in a population of adolescents/young adults who had been treated for EA in early infancy. All eligible patients received upper gastrointestinal endoscopy under general anesthesia with standardized esophageal staged biopsies. Histological suspicion of metaplasia was confirmed centrally.

Conditions

Interventions

TypeNameDescription
PROCEDUREesophageal biopsies

Timeline

Start date
2010-02-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2015-07-13
Last updated
2015-07-13

Locations

20 sites across 4 countries: Belgium, Canada, France, Luxembourg

Source: ClinicalTrials.gov record NCT02495051. Inclusion in this directory is not an endorsement.

Esophageal Atresia: Metaplasia, Barrett (NCT02495051) · Clinical Trials Directory